Press Release

Male Artificial Urinary Sphincter Market to Grow with a CAGR of 5.35% through 2030

Rising Aging Population and Prevalence of Urological Disorders are expected to drive the Global Male Artificial Urinary Sphincter Market growth in the forecast period, 2026-2030

 

According to TechSci Research report, “Male Artificial Urinary Sphincter Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Male Artificial Urinary Sphincter Market stood at USD 253.25 Million in 2024 and is anticipated to grow with a CAGR of 5.35% in the forecast period, 2026-2030.

The global male artificial urinary sphincter (AUS) market is experiencing sustained growth, primarily driven by quality-of-life considerations. Urinary incontinence has a profound impact on patient well-being, often leading to social withdrawal, emotional distress, and diminished self-esteem. In response, healthcare providers are increasingly adopting AUS devices as a reliable and effective long-term solution, contributing to their growing integration into urological care pathways. This shift is further supported by significant investment in research and development, with ongoing clinical studies focused on enhancing device safety, efficacy, and long-term durability. These innovation efforts are expected to introduce advanced AUS systems featuring improved design, broader anatomical adaptability, and greater ease of use.

Key market drivers include the rising global prevalence of urinary incontinence particularly among men recovering from prostate surgeries or experiencing conditions such as benign prostatic hyperplasia (BPH), prostatitis, or bladder dysfunction resulting from nerve and muscle damage. In addition, the introduction of technologically advanced AUS devices, including smart and adjustable models with a wide range of cuff sizes and pressure control features, has enabled more personalized and effective treatment options. Increased healthcare expenditure in emerging markets has further accelerated access to specialized urological care, expanding the patient base.

The post-COVID-19 landscape has also played a role, as healthcare systems adapt to meet heightened demand for urological diagnostics and therapies. This includes a growing preference for minimally invasive procedures, which offer reduced recovery times, lower complication rates, and improved clinical outcomes. AUS implantation via such approaches has become increasingly attractive to both providers and patients. Collectively, these factors are driving robust and sustained growth in the male AUS market, with innovation, patient-centric care, and clinical effectiveness at the core of its expansion.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Male Artificial Urinary Sphincter Market

 

The Global Male Artificial Urinary Sphincter Market is segmented into type, end-user, regional distribution, and company.

Based on its end-user, The hospitals sector held a dominant position in the male artificial urinary sphincter market. This supremacy can be attributed to the increasing number of surgical procedures and a rising incidence of end-stage renal diseases. In the United States, over 808,000 individuals are currently living with end-stage kidney disease (ESKD), also referred to as end-stage renal disease (ESRD). Of this population, approximately 68% rely on dialysis for renal replacement therapy, while the remaining 32% have received a kidney transplant. From a demographic perspective, males face a 60% higher risk of developing ESKD compared to females. The disease burden is disproportionately higher among minority groups: Black Americans are over four times more likely to develop ESKD than White Americans. Similarly, Hispanic and Native American populations face more than double the risk, while Asian Americans exhibit a 1.6-fold increased incidence.

The segment comprising clinics and other healthcare centers is expected to experience significant growth at a considerable CAGR during the projected period. These clinics are well-equipped with the necessary medical instruments and infrastructure. Ambulatory Surgery Centers (ASCs) are specialized surgical facilities primarily focused on providing emergency or same-day surgical procedures and often linked to larger healthcare systems. ASCs offer a wide array of surgical treatments, including procedures for urinary incontinence (UI) such as sling procedures and artificial urinary sphincter (AUS) implantations, among others.

Additional healthcare facilities and centers encompass specialty surgical clinics, urology clinics, hospital-based clinics, and nonprofit healthcare systems. Furthermore, clinics present more cost-effective alternatives compared to hospitals for urological surgeries. As outpatient facilities, these clinics have lower overhead expenses and do not necessitate overnight stays, resulting in reduced overall costs for patients. They also offer shorter waiting times, adopt a patient-centered approach, and frequently employ specialized teams of urologists, nurses, and staff members who possess extensive experience and expertise in urologic surgeries.

Based on region, The North American market for male artificial urinary sphincters is anticipated to experience substantial growth in the forecast period. This can be attributed to the region's well-established healthcare infrastructure, high prevalence of urological disorders, and a strong focus on technological advancements in medical devices. North America is a prominent market for male artificial urinary sphincters, as it is used to diagnose and treat various urological conditions, including kidney stones, enlarged prostates, bladder tumors, and urinary tract strictures, with advanced procedures such as the implantation of male artificial urinary sphincters.

 

Major companies operating in Global Male Artificial Urinary Sphincter Market are:

  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Affluent Medical
  • UroMems
  • Rigicon
  • ProMinent GmbH
  • Coloplast A/S
  • Medtronic Plc
  • Stryker

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global male artificial urinary sphincter market is entering an exciting phase of innovation and growth. Minimally invasive procedures, enhanced device technology, customization, telemedicine integration, increasing patient awareness, global expansion, and ongoing research and development efforts are all expected to shape the future of this vital healthcare sector. The upcoming trends promise to offer individuals suffering from urinary incontinence more effective, personalized, and accessible solutions for enhancing their quality of life. As the male artificial urinary sphincter market evolves, it exemplifies the relentless pursuit of innovation in the quest to improve patient outcomes and well-being” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component)), By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Male Artificial Urinary Sphincter Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Male Artificial Urinary Sphincter Market.


Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com